Here are four things to know.
1. Drugmakers are prohibited from charging the VA more than a maximum amount — or federal ceiling price — for covered drugs under the Veterans Health Care Act.
2. Swiftwater, Pa.-based Sanofi Pasteur informed the VA it miscalculated the federal ceiling price for various drugs from 2002 to 2011, thereby overcharging the VA, according to the DOJ.
3. Along with paying the $19.8 million settlement amount, Sanofi Pasteur agreed not to pursue reimbursement claims for the sale of drugs it undercharged the VA for due to the miscalculation.
4. Sanofi Pasteur “cooperated fully and negotiated in good faith with the government,” a company spokeswoman told Reuters via email.
More articles on supply chain:
Boston Scientific to buy Swiss devicemaker for $435M
How SSM Health’s pharmacy concierge program helps patients manage high drug costs
Viewpoint: US should strengthen existing laws to lower drug prices — not make new ones
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
